Toxicity of 6-hydroxydopamine: Live cell imaging of cytoplasmic redox flux

Cell Biology and Toxicology

Volumn 28, Issue 2, 2012, Pages 89-101

  Dooley, Colette T ^a   Li, Ling ^a   Misler, Jaime A ^a   Thompson, Jane H ^a  

^a TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

Author keywords

Dopamine; Green fluorescent protein; Hydrogen peroxide; Neuroblastoma; Oxidative stress; Redox

Indexed keywords

GLUCOSE; GREEN FLUORESCENT PROTEIN; HYDROGEN PEROXIDE; OXIDOPAMINE;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; DRUG CYTOTOXICITY; DRUG MECHANISM; GLUCOSE METABOLISM; IMAGE ANALYSIS; IMAGE DISPLAY; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; MOLECULAR DYNAMICS; MOLECULAR IMAGING; MOLECULAR INTERACTION; NEUROBLASTOMA CELL; NONHUMAN; OUTCOME ASSESSMENT; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ACETYLCYSTEINE; ARGININE; CELL CULTURE TECHNIQUES; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; CLONING, MOLECULAR; CULTURE MEDIA; CYTOPLASM; GLUCOSE; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; MOLECULAR IMAGING; MUTATION; NEURONS; OXIDATION-REDUCTION; OXIDATIVE STRESS; OXIDOPAMINE; PHENYLALANINE; TOXICITY TESTS; TRANSFECTION;

EID: 84859164120     PISSN: 07422091     EISSN: 15736822     Source Type: Journal    
DOI: 10.1007/s10565-011-9209-3     Document Type: Article

References (38)

1. Andrew R, Watson DG, Best SA, Midgley JM, Wenlong H, Petty RK. The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls. Neurochem Res. 1993;18:1175-7. (Pubitemid 23306353)
2. Bellucci A, Collo G, Sarnico I, Battistin L, Missale C, Spano P. Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation. J Neurochem. 2008;106:560-77.
3. Belousov VV, Fradkov AF, Lukyanov KA, Staroverov DB, Shakhbazov KS, Terskikh AV, Lukyanov S. Genetically encoded fluorescent indicator for intracellular hydrogen peroxide. Nat Methods. 2006;3:281-6.
4. Ben-Yoseph O, Boxer PA, Ross BD. Assessment of the role of the glutathione and pentose phosphate pathways in the protection of primary cerebrocortical cultures from oxidative stress. J Neurochem. 1996;66:2329-37. (Pubitemid 26159067)
5. Blum D, Torch S, Lambeng N, Nissou M, Benabid AL, Sadoul R, Verna JM. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol. 2001;65:135-72. (Pubitemid 32524182)
6. Blum D, Torch S, Nissou MF, Benabid AL, Verna JM. Extracellular toxicity of 6-hydroxydopamine on PC12 cells. Neurosci Lett. 2000;283:193-6. (Pubitemid 30168965)
7. Brenner-Lavie H, Klein E, Ben-Shachar D. Mitochondrial complex I as a novel target for intraneuronal DA: modulation of respiration in intact cells. Biochem Pharmacol. 2009;78:85-95.
8. Callio J, Oury TD, Chu CT. Manganese superoxide dismutase protects against 6-hydroxydopamine injury in mouse brains. J Biol Chem. 2005;280:18536-42. (Pubitemid 41389104)
9. Cannon MB, Remington SJ. Re-engineering redox-sensitive green fluorescent protein for improved response rate. Protein Sci. 2006;15:45-57. (Pubitemid 43004232)
10. Chalovich EM, Zhu JH, Caltagarone J, Bowser R, Chu CT. Functional repression of cAMP response element in 6-hydroxydopamine-treated neuronal cells. J Biol Chem. 2006;281:17870-81. (Pubitemid 44035586)
11. Chen J, Wersinger C, Sidhu A. Chronic stimulation of D1 dopamine receptors in human SK-N-MC neuroblastoma cells induces nitric-oxide synthase activation and cytotoxicity. J Biol Chem. 2003;278:28089-100. (Pubitemid 36900006)
12. Clement MV, Long LH, Ramalingam J, Halliwell B. The cytotoxicity of dopamine may be an artefact of cell culture. J Neurochem. 2002;81:414-21. (Pubitemid 34809320)
13. Curtius HC, Wolfensberger M, Steinmann B, Redweik U, Siegfried J. Mass fragmentography of dopamine and 6-hydroxydopamine. Application to the determination of dopamine in human brain biopsies from the caudate nucleus. J Chromatogr. 1974;99:529-40.
14. Delgado-Esteban M, Almeida A, Bolanos JP. D-Glucose prevents glutathione oxidation and mitochondrial damage after glutamate receptor stimulation in rat cortical primary neurons. J Neurochem. 2000;75:1618-24.
15. Dooley CT, Dore TM, Hanson GT, Jackson WC, Remington SJ, Tsien RY. Imaging dynamic redox changes in mammalian cells with green fluorescent protein indicators. J Biol Chem. 2004;279:22284-93. (Pubitemid 38679425)
16. Gutscher M, Pauleau AL, Marty L, Brach T, Wabnitz GH, Samstag Y, Meyer AJ, Dick TP. Real-time imaging of the intracellular glutathione redox potential. Nat Methods. 2008;5:553-9. (Pubitemid 351761764)
17. Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging. 2001;18:685-716. (Pubitemid 32948277)
18. Hanson GT, Aggeler R, Oglesbee D, Capaldi RA, Tsien RY, Remington SJ. Investigating mitochondrial redox potential with redox-sensitive green fluorescent protein indicators. J Biol Chem. 2004;279:13044-53. (Pubitemid 38445882)
19. Hara H, Kamiya T, Adachi T. Endoplasmic reticulum stress inducers provide protection against 6-hydroxydopamine-induced cytotoxicity. Neurochem Int. 2011;58:35-43.
20. Hwang C, Sinskey AJ, Lodish HF. Oxidized redox state of glutathione in the endoplasmic reticulum. Science. 1992;257:1496-502.
21. Isaev NK, Stelmashook EV, Dirnagl U, Plotnikov EY, Kuvshinova EA, Zorov DB. Mitochondrial free radical production induced by glucose deprivation in cerebellar granule neurons. Biochemistry (Mosc). 2008;73:149-55. (Pubitemid 351374342)
22. Izumi Y, Sawada H, Sakka N, Yamamoto N, Kume T, Katsuki H, Shimohama S, Akaike A. p-Quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly. J Neurosci Res. 2005;79:849-60. (Pubitemid 40476509)
23. Jiang H, Jiang Q, Feng J. Parkin increases dopamine uptake by enhancing the cell surface expression of dopamine transporter. J Biol Chem. 2004;279:54380-6. (Pubitemid 40053177)
24. Jiang Y, Pei L, Li S, Wang M, Liu F. Extracellular dopamine induces the oxidative toxicity of SH-SY5Y cells. Synapse. 2008;62:797-803.
25. Jordan J, Galindo MF, Tornero D, Gonzalez-Garcia C, Cena V. Bcl-x L blocks mitochondrial multiple conductance channel activation and inhibits 6-OHDA-induced death in SH-SY5Y cells. J Neurochem. 2004;89:124-33. (Pubitemid 38420681)
26. Kulich SM, Chu CT. Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson's disease. J Neurochem. 2001;77:1058-66. (Pubitemid 32467060)
27. Lehmensiek V, Tan EM, Liebau S, Lenk T, Zettlmeisl H, Schwarz J, Storch A. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease. Neurochem Int. 2006;48:329-40. (Pubitemid 43327272)
28. Liu S, Ansari NH, Wang C, Wang L, Srivastava SK. A rapid HPLC method for the quantification of GSH and GSSG in ocular lens. Curr Eye Res. 1996;15:726-32. (Pubitemid 26258398)
29. Lotharius J, Dugan LL, O'Malley KL. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J Neurosci. 1999;19:1284-93. (Pubitemid 29088911)
30. Miller GM, Yatin SM, De La Garza R, Goulet M, Madras BK. Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity. Brain Res Mol Brain Res. 2001;87:124-43. (Pubitemid 32167048)
31. Pedelacq JD, Cabantous S, Tran T, Terwilliger TC, Waldo GS. Engineering and characterization of a superfolder green fluorescent protein. Nat Biotechnol. 2006;24:79-88. (Pubitemid 43083170)
32. Saito Y, Nishio K, Ogawa Y, Kinumi T, Yoshida Y, Masuo Y, Niki E. Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: involvement of hydrogen peroxide-dependent and -independent action. Free Radic Biol Med. 2007;42:675-85. (Pubitemid 46205147)
33. Senoh S, Creveling CR, Udenfriend S, Witkop B. Chemical, enzymatic and metabolic studies on the mechanism of oxidation of dopamine. J Am Chem Soc. 1959;81:6236-40.
34. Soto-Otero R, Mendez-Alvarez E, Hermida-Ameijeiras A, Munoz-Patino AM, Labandeira-Garcia JL. Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease. J Neurochem. 2000;74:1605-12. (Pubitemid 30163982)
35. Uttara B, Singh AV, Zamboni P, Mahajan RT. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol. 2009;7:65-74.
36. Wilson JE. Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J Exp Biol. 2003;206:2049-57. (Pubitemid 36761808)
37. Zhou C, Huang Y, Przedborski S. Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance. Ann N Y Acad Sci. 2008;1147:93-104.
38. Zhu X, Su B, Wang X, Smith MA, Perry G. Causes of oxidative stress in Alzheimer disease. Cell Mol Life Sci. 2007;64:2202-10. (Pubitemid 47347959)